The UK’s Medicines and Healthcare products Regulatory Agency (MHRA) has approved Adzynma (apadamtase alfa/cinaxadamtase alfa; ...

Swiss pharma giant Roche (ROG: SIX), the Breast International Group (BIG), Institut Jules Bordet Clinical Trials Support Unit ...

Chinese biotech Minghui Pharmaceutical has sold certain rights to its experimental cancer drug MHB088C to Qilu Pharmaceutical ...

Swiss pharma giant Roche is investing $280 million to build a new biopharma manufacturing facility in Shanghai, as it doubles ...

Spanish dermatology specialist Almirall was the envy of investors on Monday, with its share price closing 10% higher.

US pharma firm BioMarin Pharmaceutical (Nasdaq: BMRN) saw its shares rise nearly 4% to $61.09 this morning, after it released positive new data for its Voxzogo (vosoritide).

Japanese drugmaker Shionogi (TYO: 4507) has entered into a joint research agreement with French firm Cilcare for the creation ...

US healthcare giant Johnson & Johnson has announced new data from the Phase III ICONIC-TOTAL study investigating icotrokinra ...

The Indian subsidiary of UK pharma major AstraZeneca has announced a Central Drugs Standard Control Organization (CDSCO) approval to import for sale and distribution of trastuzumab deruxtecan ...

Boston, USA-based biotech Aera Therapeutics, which is harnessing next-generation enabling delivery technologies and precision ...

US President Donald Trump sent shivers through the pharmaceutical industry as he vowed to dramatically reduce the high drug prices that have long been a feature of the US market.

Denmark, oncology-based Pharmacosmos today announced that it has assumed the worldwide rights, excluding select Asia-Pacific ...